ENHERTU

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: 75b8e269c8ce0f69
Drug Approval Canada Name: ENHERTU
Product Name: ENHERTU
Status: Marketed
Status Date: 2021-07-09
Original Market Date: 2021-07-09
Din: 02514400
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FD04 TRASTUZUMAB DERUXTECAN
Atc Name: l 01 fd 04
Aig Number: 0162807001
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

TRASTUZUMAB DERUXTECAN

100 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

75b8e269c8ce0f69

Type

Standard